Abstract
Objective
Improve regional clinical care for infants with neonatal encephalopathy presumed to be due to hypoxic-ischemic encephalopathy (HIE) by developing a clinical data registry.
Study design
We developed a regional multicenter registry of newborns at risk for HIE and leveraged data collected within the registry to design and monitor biannually quality improvement metrics in a collaborative effort among site investigators.
Result
Over the 3 years since beginning our improvement efforts, we have demonstrated positive trends in all three initial metrics decided on by our investigators: increasing the cord blood gas acquisition in high-risk deliveries (median 74–87%); increasing neurological exam and encephalopathy score documentation in infants with perinatal acidosis (17–36%); and decreasing the incidence of infants discharged on anti-seizure medication (60–29%).
Conclusion
In addition to providing hypothesis-generating research data, local and regional registry data can be successfully utilized for quality improvement efforts across multiple hospitals.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to the full article PDF.
USD 39.95
Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others
Data availability
The dataset analyzed for the current study are available from the corresponding author on reasonable request.
References
Gunn AJ, Thoresen M. Neonatal encephalopathy and hypoxic-ischemic encephalopathy. Handb Clin Neurol. 2019;162:217–37. https://doi.org/10.1016/B978-0-444-64029-1.00010-2.
Wassink G, Gunn ER, Drury PP, Bennet L, Gunn AJ. The mechanisms and treatment of asphyxial encephalopathy. Front Neurosci. 2014;8. https://doi.org/10.3389/fnins.2014.00040.
Pierrat V, Haouari N, Liska A, Thomas D, Subtil D, Truffert P, et al. Prevalence, causes, and outcome at 2 years of age of newborn encephalopathy: population based study. Arch Dis Child Fetal Neonatal Ed. 2005;90:F257–F261. https://doi.org/10.1136/adc.2003.047985.
Allen KA, Brandon DH. Hypoxic ischemic encephalopathy: pathophysiology and experimental treatments. Newborn Infant Nurs Rev NAINR. 2011;11:125–33. https://doi.org/10.1053/j.nainr.2011.07.004.
Kurinczuk JJ, White-Koning M, Badawi N. Epidemiology of neonatal encephalopathy and hypoxic-ischaemic encephalopathy. Early Hum Dev. 2010;86:329–38. https://doi.org/10.1016/j.earlhumdev.2010.05.010.
Azzopardi D, Strohm B, Marlow N, Brocklehurst P, Deierl A, Eddama O, et al. Effects of hypothermia for perinatal asphyxia on childhood outcomes. N Engl J Med. 2014;371:140–9. https://doi.org/10.1056/NEJMoa1315788.
Edwards AD, Brocklehurst P, Gunn AJ, Halliday H, Juszczak E, Levene M, et al. Neurological outcomes at 18 months of age after moderate hypothermia for perinatal hypoxic ischaemic encephalopathy: synthesis and meta-analysis of trial data. BMJ. 2010;340:c363. https://doi.org/10.1136/bmj.c363.
Jacobs SE, Berg M, Hunt R, Tarnow-Mordi WO, Inder TE, Davis PG. Cooling for newborns with hypoxic ischaemic encephalopathy. Cochrane Database Syst Rev. 2013;CD003311. https://doi.org/10.1002/14651858.CD003311.pub3.
Natarajan G, Pappas A, Shankaran S. Outcomes in childhood following therapeutic hypothermia for neonatal hypoxic-ischemic encephalopathy (HIE). Semin Perinatol. 2016;40:549–55. https://doi.org/10.1053/j.semperi.2016.09.007.
Nelson KB, Bingham P, Edwards EM, Horbar J, Kenny M, Inder T, et al. Antecedents of neonatal encephalopathy in the Vermont Oxford Network encephalopathy registry. Pediatrics. 2012;130:878–86. https://doi.org/10.1542/peds.2012-0714.
Okulu E, Hirfanoglu IM, Satar M, Erdeve O, Koc E, Ozlu F, et al. An observational, multicenter, registry-based cohort study of Turkish Neonatal Society in neonates with Hypoxic ischemic encephalopathy. PLOS One. 2023;18:e0295759. https://doi.org/10.1371/journal.pone.0295759.
Beltempo M, Wintermark P, Mohammad K, Jabbour E, Afifi J, Shivananda S, et al. Variations in practices and outcomes of neonates with hypoxic ischemic encephalopathy treated with therapeutic hypothermia across tertiary NICUs in Canada. J Perinatol. 2022;42:898–906. https://doi.org/10.1038/s41372-022-01412-7.
Quinones Cardona V, Rao R, Zaniletti I, Joe P, Johnson Y, DiGeronimo R, et al. Association of hospital resource utilization with neurodevelopmental outcomes in neonates with hypoxic-ischemic encephalopathy. JAMA Netw Open. 2023;6:e233770. https://doi.org/10.1001/jamanetworkopen.2023.3770.
Rao R, Mietzsch U, DiGeronimo R, Hamrick SE, Dizon MLV, Lee K, et al. Utilization of therapeutic hypothermia and neurological injury in neonates with mild hypoxic-ischemic encephalopathy: a report from Children’s Hospital Neonatal Consortium. Am J Perinatol. 2022;39:319–28. https://doi.org/10.1055/s-0040-1716341.
Rao R, Lee KS, Zaniletti I, Yanowitz TD, DiGeronimo R, Dizon MLV, et al. Antimicrobial therapy utilization in neonates with hypoxic-ischemic encephalopathy (HIE): a report from the Children’s Hospital Neonatal Database (CHND). J Perinatol. 2020;40:70–78. https://doi.org/10.1038/s41372-019-0527-2.
Dizon MLV, Rao R, Hamrick SE, Zaniletti I, DiGeronimo R, Natarajan G, et al. Practice variation in anti-epileptic drug use for neonatal hypoxic-ischemic encephalopathy among regional NICUs. BMC Pediatr. 2019;19:67. https://doi.org/10.1186/s12887-019-1441-7.
El-Dib M, El-Shibiny H, Walsh B, Cherkerzian S, Boulanger J, Bates SV, et al. Establishing a regional registry for neonatal encephalopathy: impact on identification of gaps in practice. Pediatr Res. 2024;95:213–22. https://doi.org/10.1038/s41390-023-02763-3.
Pfister RH, Bingham P, Edwards EM, Horbar JD, Kenny MJ, Inder T, et al. The Vermont Oxford Neonatal Encephalopathy Registry: rationale, methods, and initial results. BMC Pediatr. 2012;12:84. https://doi.org/10.1186/1471-2431-12-84.
Blecharczyk E, Lee L, Birnie K, Gupta A, Davis A, Van Meurs K, et al. Standardized evaluation of cord gases in neonates at risk for hypoxic ischemic encephalopathy. Hosp Pediatr. 2021;12:29–37. https://doi.org/10.1542/hpeds.2021-006135.
Committee on Fetus and Newborn. Hypothermia and neonatal encephalopathy. Pediatrics. 2014;133:1146–50. https://doi.org/10.1542/peds.2014-0899.
Donn SM, Chiswick ML, Fanaroff JM. Medico-legal implications of hypoxic-ischemic birth injury. Semin Fetal Neonatal Med. 2014;19:317–21. https://doi.org/10.1016/j.siny.2014.08.005.
Fineschi V, Viola RV, La Russa R, Santurro A, Frati P. A controversial medicolegal issue: timing the onset of perinatal hypoxic-ischemic brain injury. Mediators Inflamm. 2017;2017:6024959. https://doi.org/10.1155/2017/6024959.
Schifrin BS, Soliman M, Koos B. Litigation related to intrapartum fetal surveillance. Best Pract Res Clin Obstet Gynaecol. 2016;30:87–97. https://doi.org/10.1016/j.bpobgyn.2015.06.007.
Sewell EK, Shankaran S, McDonald SA, Hamrick S, Wusthoff CJ, Adams-Chapman I, et al. Antiseizure medication at discharge in infants with hypoxic-ischaemic encephalopathy: an observational study. Arch Dis Child Fetal Neonatal Ed. 2023;108:421–8. https://doi.org/10.1136/archdischild-2022-324612.
Shellhaas RA, Chang T, Wusthoff CJ, Soul JS, Massey SL, Chu CJ, et al. Treatment duration after acute symptomatic seizures in neonates: a multicenter cohort study. J Pediatr. 2017;181:298–301.e1. https://doi.org/10.1016/j.jpeds.2016.10.039.
Bittigau P, Sifringer M, Genz K, Reith E, Pospischil D, Govindarajalu S, et al. Antiepileptic drugs and apoptotic neurodegeneration in the developing brain. Proc Natl Acad Sci. 2002;99:15089–94. https://doi.org/10.1073/pnas.222550499.
Farwell JR, Lee YJ, Hirtz DG, Sulzbacher SI, Ellenberg JH, Nelson KB. Phenobarbital for febrile seizures — effects on intelligence and on seizure recurrence. N Engl J Med. 1990;322:364–9. https://doi.org/10.1056/NEJM199002083220604.
Pisani F, Facini C, Pavlidis E, Spagnoli C, Boylan G. Epilepsy after neonatal seizures: literature review. Eur J Paediatr Neurol. 2015;19:6–14. https://doi.org/10.1016/j.ejpn.2014.10.001.
Glass HC, Grinspan ZM, Shellhaas RA. Outcomes after acute symptomatic seizures in neonates. Semin Fetal Neonatal Med. 2018;23:218–22. https://doi.org/10.1016/j.siny.2018.02.001.
Glass HC, Soul JS, Chang T, Wusthoff CJ, Chu CJ, Massey SL, et al. Safety of early discontinuation of antiseizure medication after acute symptomatic neonatal seizures. JAMA Neurol. 2021;78:817–25. https://doi.org/10.1001/jamaneurol.2021.1437.
Acknowledgements
We would like to thank all the patients and clinicians caring for the patients across all the registry sites. Additionally, we would like to thank all the registry staff and investigators (listed in Supplementary File 2).
Author information
Authors and Affiliations
Consortia
Contributions
FA, AAB, and EP conceptualized the study; FA and EP performed the analysis and prepared the original draft of the manuscript; FA, JE, NT, AJ, AAB, and EP interpreted the data and critically reviewed and revised the final manuscript.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interest.
Ethics approval and consent to participate
All methods were performed in accordance with the relevant guidelines and regulations. The University of Nebraska Medical Center Institutional Review Board approved this study as a central IRB (0639-17-EP). All subjects enrolled under the central IRB provided informed consent for their inclusion. One site chose to submit their own application due to a lack of follow up data eliminating the need to collect protected health information. The UnityPoint Health Institutional Review Board approved that site’s arm of the study (IM2019-084), including a waiver of consent.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Al-Sammak, F.M., Euteneuer, J.C., Townley, N. et al. Harnessing a neonatal encephalopathy registry for regional quality improvement efforts. J Perinatol (2026). https://doi.org/10.1038/s41372-025-02533-5
Received:
Revised:
Accepted:
Published:
Version of record:
DOI: https://doi.org/10.1038/s41372-025-02533-5

